The MILES Study is a longitudinal, mixed-methods investigation of urinary biomarkers, energy balance, and lifestyle modifications in diverse women during early breast cancer treatment. The study's overarching goal is to assess dietary quality and physical activity changes over time using reliable, scalable tools suitable for clinical or population settings, supporting newly diagnosed patients in adopting and maintaining healthy behaviors through treatment and survivorship.
Adult women (age 18 years or older)
Able to read English or Spanish
Newly diagnosed with primary stage 0, I, II, or III breast cancer
Pathological diagnosis within the previous 60 days
Women age less than 18 years
Women without a new primary breast cancer diagnosis
Women who are pregnant
Abramson Cancer Center at Penn Medicine
Lead sponsor
Penn State University
Collaborator